Telefones: (21) 3812-2600 / (11) 2634-8000
enEN
ptPT

GSH LEARNING - CONTINUING EDUCATION

| TECHNICAL CLASSES | MEDICAL SYMPOSIUM | SCIENTIFIC PRODUCTION | TECHNICAL COURSES | NATIONAL & INTERNATIONAL CONFERENCES |

Own development and qualification platform for physicians, managers, and technicians.

A total of 12 annual medical symposia (Blood Boards) with technical classes on relevant subjects of Transfusion Medicine and Cell Therapy.

Extensive training programs  for professionals from partner hospitals with a focus on important blood therapy topics:

  • null
    Rational use of blood components;
  • null
    Prescription of special blood components;
  • null
    Universal leukoreduction, among others.

Continuous investment  in training and development programs for employees, as well as for the teams allocated to partner hospitals.

We hold on average 50 annual training hours per employee. That number is 50% higher than the average of other institutions in the national healthcare industry.

Over 140 scientific papers published in national and international conferences.

TEACHING & RESEARCH

LINES OF RESEARCH: HEMOTHERAPY

Transfusion profile of patients hospitalized with COVID-19 in Brazil

An important observational study published by the international journal Vox Sanguinis, a journal edited by the ISBT (International Society for Blood Transfusion), had the collaboration of hematologists who are part of the renowned clinical staff of the GSH Group. By analyzing the medical records of patients diagnosed with COVID-19, the group described the transfusion needs, characteristics and clinical outcomes of 3,014 patients in 16 hospitals located in 6 Brazilian states. The knowledge of the transfusion profile of these patients allowed us to improve strategies for the maintenance of blood supplies in hospitals during the pandemic and to reinforce our commitment to significantly contribute to the advancement of worldwide research on COVID-19.

LINES OF RESEARCH: HEMOTHERAPY

Use of convalescent plasma in the treatment of patients with COVID-19

The GSH Group, in partnership with IDOR (Instituto D’Or de Pesquisa e Ensino) and HCor (Hospital do Coração), conducts research, authorized by CONEP, with the plasma of individuals who have already tested positive for the coronavirus. In this study, people who are infected and have stopped presenting symptoms in the last 30 days donate blood plasma to be administered to patients in advanced stages of COVID-19. Collection and storage are carried out by the GSH Group, and treatment is administered by IDOR and HCOR.

LINES OF RESEARCH: AUTOTRANSFUSION

Intraoperative blood recovery in cardiac surgery

Research carried out by our medical vice president – Dr. Sergio Vieira, in partnership with physicians at HCor, on intraoperative blood recovery presents the rational use of blood.

LINES OF RESEARCH: QUALITY MANAGEMENT AND TRANSFUSION SAFETY

Digitizing patient identification

The model of care safety adopted by the GSH Group is comprised of a system for reading individual bar codes on bracelets by a computerized system. The objective is to improve patient safety, minimizing errors and obtaining traceability and efficiency throughout the entire blood transfusion process.

Menu

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you have provided to them or that they have collected from your use of their services. You consent to our cookies if you continue to use our website.

Preference Allow All Disable All